Selected Projects

Our Project Experience

A selection of policy studies, field research, pharmacoeconomic model adaptations and project consultancy work conducted by KH Consulting.

Policy Studies

  • Budget Burden Study for Enzyme Replacement Therapies, 2025
  • Early Access to Medicines in Türkiye Study, 2023
  • Chronic Kidney Disease Budget Burden Study, 2022
  • Lung Cancer Roadmap Study, 2018
  • Lung Cancer Support Network Study, 2017
  • Viral Hepatitis Control Program, 2015
  • Melanoma Roadmap Study, 2014
  • AIFD Strategic Planning Study, 2010
  • Patient Access to Cancer Medicines in Türkiye Study (PACT Project), 2009

Field Research

  • Hypochondroplasia Patient Journey Research, 2026
  • Hypochondroplasia Quality of Life Research, 2026
  • Evaluation of Disease Management Experiences of Children with Achondroplasia and Their Families, 2025
  • Hemophilia A Patient Journey Research, 2024
  • Hemophilia A Treatment Market Research, 2024
  • Achondroplasia Treatment Market Research, 2024
  • Hemophilia Disease Burden Research, 2023
  • Achondroplasia Quality of Life Research, 2023
  • Phenylketonuria Treatment Market Research, 2022
  • Cost-Effectiveness Evaluation of Home Care Services Research, 2022
  • Phenylketonuria Patient Journey Research, 2021
  • Atrial Fibrillation and Stroke Disease Burden Research, 2021
  • MPS Treatment Adherence Research, 2021

Pharmacoeconomic Model Adaptation

  • Avacincaptad pegol
  • Bimekizumab
  • Dapagliflozin
  • Datopotamab Deruxtecan
  • Durvalumab
  • Enfortumab
  • Enzalutamid
  • Galsulfase
  • Gilterinitib
  • Ipilimumab
  • Naglazaym
  • Neratinib
  • Nivolumab
  • Pegvaliase-pqpz
  • Roxadustrad
  • Sodyum zirkonyum siklosilikat
  • Sotorasib
  • Ticagrelor
  • Trastuzumab Deruxtecan
  • Valoctocogene roxaparvovec
  • Vosoritid
  • Zolbetuximab

Rare Disease Experience

  • Achondroplasia
  • Hypochondroplasia
  • MPS
  • Phenylketonuria
  • Hemophilia A
  • Hemophilia B
  • Dravet syndrome
  • Gaucher disease
  • ATTR amyloidosis
  • Chronic inflammatory demyelinating polyneuropathy (CIDP)
  • Autoimmune hemolytic anemia
  • Amyotrophic lateral sclerosis (ALS)

Patient Association Support Studies

  • PKU Family Association
  • MPS-LH Association
  • Achondroplasia and Families Association

Contact

Let's Bring Your Project to Life

Get in touch with KH Consulting's expert team for Policy Studies for Market Access, Product Positioning, GMP and Marketing Authorisation Priority Application Preparation, Reimbursement Applications, Pharmacoeconomic Model Adaptation, Disease Journey Studies, Burden of Disease Studies, Quality of Life Studies and Market Research.

Contact Us